Literature DB >> 27815365

Xanthohumol Modulates Calcium Signaling in Rat Ventricular Myocytes: Possible Antiarrhythmic Properties.

Juan Jose Arnaiz-Cot1, Lars Cleemann1, Martin Morad2.   

Abstract

Cardiac arrhythmia is a major cause of mortality in cardiovascular pathologies. A host of drugs targeted to sarcolemmal Na+, Ca2+, and K+ channels has had limited success clinically. Recently, Ca2+ signaling has been target of pharmacotherapy based on finding that leaky ryanodine receptors elevate local Ca2+ concentrations causing membrane depolarizations that trigger arrhythmias. In this study, we report that xanthohumol, an antioxidant extracted from hops showing therapeutic effects in other pathologies, suppresses aberrant ryanodine receptor Ca2+ release. The effects of xanthohumol (5-1000 nM) on Ca2+ signaling pathways were probed in isolated rat ventricular myocytes incubated with Fluo-4 AM using the perforated patch-clamp technique. We found that 5-50 nM xanthohumol reduced the frequency of spontaneously occurring Ca2+ sparks (>threefold) and Ca2+ waves in control myocytes and in cells subjected to Ca2+ overload caused by the following: 1) exposure to low K+ solutions, 2) periods of high frequency electrical stimulation, 3) exposures to isoproterenol, or 4) caffeine. At room temperatures, 50-100 nM xanthohumol reduced the rate of relaxation of electrically- or caffeine-triggered Ca2+transients, without suppressing ICa, but this effect was small and reversed by isoproterenol at physiologic temperatures. Xanthohumol also suppressed the Ca2+ content of the SR and its rate of recirculation. The stabilizing effects of xanthohumol on the frequency of spontaneously triggered Ca2+ sparks and waves combined with its antioxidant properties, and lack of significant effects on Na+ and Ca2+ channels, may provide this compound with clinically desirable antiarrhythmic properties.
Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27815365      PMCID: PMC5193078          DOI: 10.1124/jpet.116.236588

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  38 in total

1.  Xanthohumol modulates the expression of osteoclast-specific genes during osteoclastogenesis in RAW264.7 cells.

Authors:  Kwang Sik Suh; Sang Youl Rhee; Young Seol Kim; Young Soon Lee; Eun Mi Choi
Journal:  Food Chem Toxicol       Date:  2013-08-27       Impact factor: 6.023

2.  Two-dimensional confocal images of organization, density, and gating of focal Ca2+ release sites in rat cardiac myocytes.

Authors:  L Cleemann; W Wang; M Morad
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

3.  A uniform enzymatic method for dissociation of myocytes from hearts and stomachs of vertebrates.

Authors:  R Mitra; M Morad
Journal:  Am J Physiol       Date:  1985-11

4.  In vitro studies on the inhibition of colon cancer by butyrate and polyphenolic compounds.

Authors:  Pedro Gonçalves; João R Araújo; M João Pinho; Fátima Martel
Journal:  Nutr Cancer       Date:  2011       Impact factor: 2.900

Review 5.  Ryanodine receptors of striated muscles: a complex channel capable of multiple interactions.

Authors:  C Franzini-Armstrong; F Protasi
Journal:  Physiol Rev       Date:  1997-07       Impact factor: 37.312

6.  Protective effect of xanthohumol on toxin-induced liver inflammation and fibrosis.

Authors:  Christoph Dorn; Jörg Heilmann; Claus Hellerbrand
Journal:  Int J Clin Exp Pathol       Date:  2012-01-01

7.  Xanthohumol suppresses inflammatory response to warm ischemia-reperfusion induced liver injury.

Authors:  Christoph Dorn; Sabine Massinger; Andreas Wuzik; Jörg Heilmann; Claus Hellerbrand
Journal:  Exp Mol Pathol       Date:  2012-05-23       Impact factor: 3.362

8.  SR calcium handling and calcium after-transients in a rabbit model of heart failure.

Authors:  Antonius Baartscheer; Cees A Schumacher; Charly N W Belterman; Ruben Coronel; Jan W T Fiolet
Journal:  Cardiovasc Res       Date:  2003-04-01       Impact factor: 10.787

9.  Mitochondria: from basic biology to cardiovascular disease.

Authors:  Elizabeth Murphy; Donald Bers; Rosario Rizzuto
Journal:  J Mol Cell Cardiol       Date:  2009-03-14       Impact factor: 5.000

10.  Xanthohumol prevents atherosclerosis by reducing arterial cholesterol content via CETP and apolipoprotein E in CETP-transgenic mice.

Authors:  Hiroshi Hirata; Shuichi Segawa; Moeko Ozaki; Naoyuki Kobayashi; Tatsuro Shigyo; Hitoshi Chiba
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

View more
  2 in total

1.  Xanthohumol Blocks Proliferation and Migration of Vascular Smooth Muscle Cells in Vitro and Reduces Neointima Formation in Vivo.

Authors:  Rongxia Liu; Elke H Heiss; Daniel Schachner; Baohong Jiang; Wanhui Liu; Johannes M Breuss; Verena M Dirsch; Atanas G Atanasov
Journal:  J Nat Prod       Date:  2017-06-19       Impact factor: 4.050

2.  Xanthohumol Inhibits TGF-β1-Induced Cardiac Fibroblasts Activation via Mediating PTEN/Akt/mTOR Signaling Pathway.

Authors:  Chuanhao Jiang; Ning Xie; Taoli Sun; Wanjun Ma; Bikui Zhang; Wenqun Li
Journal:  Drug Des Devel Ther       Date:  2020-12-07       Impact factor: 4.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.